Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX8LLQ
|
||||
Drug Name |
2-(1-(3-(7-propyl-3-(trifluoromethyl)benzo[d]isoxazol-6-yloxy)propyl)-1H-benzo[d][1,2,3]triazol-5-yl)acetic acid
|
||||
Synonyms |
CHEMBL208567
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H21F3N4O4
|
||||
Canonical SMILES |
CCCc1c(OCCCn2nnc3cc(CC(=O)O)ccc23)ccc4c(noc14)C(F)(F)F
|
||||
InChI |
InChI=1S/C22H21F3N4O4/c1-2-4-14-18(8-6-15-20(14)33-27-21(15)22(23,24)25)32-10-3-9-29-17-7-5-13(12-19(30)31)11-16(17)26-28-29/h5-8,11H,2-4,9-10,12H2,1H3,(H,30,31)
|
||||
InChIKey |
CQTCWVWUQDCTSG-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Peroxisomeproliferator activated receptor delta | Target Info | [1587926] | ||
Oxysterols receptor LXR-alpha | Target Info | [1587926] | |||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Wnt signaling pathway | ||||
WikiPathways | Wnt Signaling Pathway and Pluripotency | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
NRF2 pathway | |||||
Nuclear Receptors Meta-Pathway | |||||
Vitamin D Receptor Pathway | |||||
Ectoderm Differentiation | |||||
Adipogenesis | |||||
Nuclear ReceptorsWP299:Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
PPAR Alpha Pathway | |||||
Liver X Receptor Pathway | |||||
SREBF and miR33 in cholesterol and lipid homeostasis | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.